Patents Examined by John Brusca
-
Patent number: 9110030Abstract: The present invention is drawn toward a lateral-flow, colorimetric, gelatinase assay including a sample pad, a reagent pad, a membrane, and an absorbent pad, in that order, wherein the reagent pad has therein a dried form of gelatin-coated nanoparticles in a salt and sugar matrix, and wherein the membrane portion has a test stripe and a control stripe, such that the test stripe is a solution of electrolyte evaporated into a layer, and the control stripe is a solution of anti-gelatin antibody evaporated into a layer. The present invention is also drawn toward a method of detecting one or more gelatinases in a sample fluid using the assay, and methods of determining treatment for wound healing, cancer, ocular rosacea, periodontal disease and equine arthritis using the assay.Type: GrantFiled: July 1, 2013Date of Patent: August 18, 2015Inventor: Daniel A. Kerschensteiner
-
Patent number: 9075005Abstract: Provided are a cell analyzer, and a cell analysis method. A cell analyzer 1 includes a measurement device 2 for detecting information of each cell from a measurement specimen containing cells harvested from an epithelial tissue, and a data processing device 3 for determining appropriateness of the cell harvesting of parabasal cells and acquiring information related to canceration of the cell based on the information detected by the measurement device 2. The data processing device 3 displays on a display section a dialogue showing “cell harvesting inappropriate” when determined that the harvesting of parabasal cells is inappropriate.Type: GrantFiled: August 9, 2013Date of Patent: July 7, 2015Assignee: SYSMEX CORPORATIONInventors: Ryuichiro Ebi, Yousuke Tanaka, Junya Inoue, Shigeki Abe
-
Patent number: 9044795Abstract: At least one exemplary system comprises a tubular mesh enclosure formed from a mesh material having a nominal opening size of less than 0.5 inches, the tubular mesh enclosure having an opposing pair of ends, at least one of the opposing pair of ends sealed; and a filling surrounded by the tubular mesh enclosure; the system defining a length and a generally non-circular longitudinal cross-section defining a major width, a ratio of the length to the major width greater than approximately 40.Type: GrantFiled: May 13, 2013Date of Patent: June 2, 2015Inventor: Rodney W. Tyler
-
Patent number: 8000902Abstract: Efficient sequence specific gene silencing is possible through the use of siRNA technology. By selecting particular siRNAs by rational design, one can maximize the generation of an effective gene silencing reagent, as well as methods for silencing genes. Methods, compositions, and kits generated through rational design of siRNAs are disclosed.Type: GrantFiled: June 11, 2010Date of Patent: August 16, 2011Assignee: Dharmacon, Inc.Inventors: Anastasia Khvorova, Angela Reynolds, Devin Leake, William Marshall, Steven Read, Stephen Scaringe
-
Patent number: 7383134Abstract: A method and/or system for making determinations regarding samples from biologic sources. A computer implemented method and/or system can be used to automate parts of the analysis.Type: GrantFiled: January 14, 2003Date of Patent: June 3, 2008Inventors: James R. Piper, Ian Poole, Thomas Richard Lörch
-
Patent number: 7246012Abstract: A method for calculating distances between stimulus response curves (e.g., dose response curves) allows classification of stimuli. The response curves show how the phenotype of one or more cells changes in response to varying levels of the stimulus. Each “point” on the curve represents quantitative phenotype or signature for cell(s) at a particular level of stimulus (e.g., dose of a therapeutic). The signatures are multivariate phenotypic representations of the cell(s). They include various features of the cell(s) obtained by image analysis. To facilitate the comparison of stimuli, distances between points on the response curves are calculated. First, the response curves may be aligned on a coordinate representing a separate distance, r, from a common point of negative control (e.g., the point where no stimulus is applied). Integration on r may be used to compute the distance between two response curves. The distance between response curves is used to classify stimuli.Type: GrantFiled: July 16, 2004Date of Patent: July 17, 2007Assignee: Cytokinetics, Inc.Inventors: Vadim Kutsyy, Daniel A. Coleman, Eugeni A. Vaisberg
-
Patent number: 7124033Abstract: Methods, code, and apparatus are used to ensure that groups of experimental subjects selected for inclusion in a study are matched. Individuals are genotyped and the genotype data is used to determine the extent of mismatch between study groups. If groups show evidence of poor matching, then the genotype data is used to better match the study groups.Type: GrantFiled: April 30, 2003Date of Patent: October 17, 2006Assignee: Perlegen Sciences, Inc.Inventors: David Hinds, Renee Stokowski
-
Patent number: 7101963Abstract: The subject of the invention is the genomic sequence and the nucleotide sequences encoding polypeptides of Chlamydia pneumoniae, such as cellular envelope polypeptides, which are secreted or specific, or which are involved in metabolism, in the replication process or in virulence, polypeptides encoded by such sequences, as well as vectors including the said sequences and cells or animals transformed with these vectors. The invention also relates to transcriptional gene products of the Chlamydia pneumoniae genome, such as, for example, antisense and ribozyme molecules, which can be used to control growth of the microorganism. The invention also relates to methods of detecting these nucleic acids or polypeptides and kits for diagnosing Chlamydia pneumoniae infection. The invention also relates to a method of selecting compounds capable of modulating bacterial infection and a method for the biosynthesis or biodegradation of molecules of interest using the said nucleotide sequences or the said polypeptides.Type: GrantFiled: November 7, 2002Date of Patent: September 5, 2006Assignee: Serono Genetica Institute S.A.Inventors: Rémy Griffais, Susan K. Hoiseth, Robert J. Zagursky, Benjamin J. Metcalf, Joel A. Peek, Banumathi Sankaran, Leah D. Fletcher
-
Patent number: 7091315Abstract: The present invention relates to novel human secreted proteins and isolated nucleic acids containing the coding regions of the genes encoding such proteins. Also provided are vectors, host cells, antibodies, and recombinant methods for producing human secreted proteins. The invention further relates to diagnostic and therapeutic methods useful for diagnosing and treating diseases, disorders, and/or conditions related to these novel human secreted proteins.Type: GrantFiled: March 22, 2002Date of Patent: August 15, 2006Assignee: Human Genome Sciences, Inc.Inventors: Steven M. Ruben, Craig A. Rosen, Henrik Olsen
-
Patent number: 7078169Abstract: The present invention relates to methods of identifying genes whose expression is indicative of activation of a particular biochemical or metabolic pathway or a common set of biological reactions or functions in a cell (“regulon indicator genes”) The present invention provides an example of such an indicator gene. The present invention also relates to methods of partially characterizing a gene of unknown function by determining which biological pathways, reactions or functions its expression is associated with, thereby placing the gene within a functional genetic group or “regulon”. These partially characterized genes may be used to identify desirable therapeutic targets of biological pathways of interest (“regulon target genes”) The present invention provides examples of such target genes. Methods for identifying effectors (activators and inhibitors) of regulon target genes are provided. The present invention also provides examples of regulon target gene inhibitors.Type: GrantFiled: July 26, 2002Date of Patent: July 18, 2006Assignee: Rosetta Inpharmatics LLCInventors: Matthew Ashby, Stewart Scherer, John W. Phillips, Michael Ziman, Nicholas Marini
-
Patent number: 7074898Abstract: Compositions and methods for the therapy and diagnosis of cancer, such as prostate cancer, are disclosed. Compositions may comprise one or more prostate-specific proteins, immunogenic portions thereof, or polynucleotides that encode such portions. Alternatively, a therapeutic composition may comprise an antigen presenting cell that expresses a prostate-specific protein, or a T cell that is specific for cells expressing such a protein. Such compositions may be used, for example, for the prevention and treatment of diseases such as prostate cancer. Diagnostic methods based on detecting a prostate-specific protein, or mRNA encoding such a protein, in a sample are also provided.Type: GrantFiled: December 5, 2001Date of Patent: July 11, 2006Assignee: Corixa CorporationInventors: Jiangchun Xu, Davin C. Dillon, Jennifer L. Mitcham, Susan L. Harlocker, Yuqiu Jiang, Steven G. Reed, Michael D. Kalos, Gary R. Fanger, Marc W. Retter, John A. Stolk, Craig H. Day
-
Patent number: 7069152Abstract: An apparatus for identifying a protein, polypeptide or peptide by means of mass spectrometry and especially by tandem mass spectrometry is disclosed. The apparatus preferably functions to model the fragmentation of a peptide or protein in a tandem mass spectrometer to facilitate comparison with an experimentally determined spectrum. A fragmentation model is used which takes account of all possible fragmentation pathways which a particular sequence of amino acids may undergo. A peptide or protein may be identified by comparing an experimentally determined mass spectrum with spectra predicted using such a fragmentation model from a library of known peptides or proteins.Type: GrantFiled: September 5, 2002Date of Patent: June 27, 2006Assignee: Micromass UK LimitedInventor: John Skilling
-
Patent number: 7065450Abstract: This invention relates to a process wherein improved production of catalysts is made possible according to an evolutionary method. The principles of mutation and crossing of catalyst components and determination of performance parameters of the mixed catalysts used here are carried out in 5 to 50 catalyst generations in such way that two mixed catalysts are selected from the same generation in crossing, and at least one selected component is exchanged between the two, and in mutation of a selected mixed catalyst, a selected component from a catalyst mixture is introduced into the catalyst or, if already present in it, it is removed from the catalyst. The selection is made in all cases by using random generators with a uniform distribution. The same procedure is used for the gas flow composition, the temperature and the space velocity as the other performance parameters.Type: GrantFiled: July 19, 2001Date of Patent: June 20, 2006Assignee: Institut fur Angewandte Chemie Berlin-Adlershof e.V.Inventors: Dorit Wolf, Manfred Baerns, Olga Gerlach
-
Patent number: 7058515Abstract: “In silico” nucleic acid recombination methods, related integrated systems utilizing genetic operators and libraries made by in silico shuffling methods are provided.Type: GrantFiled: March 30, 2000Date of Patent: June 6, 2006Assignee: Maxygen, Inc.Inventors: Sergey A. Selifonov, Willem P. C. Stemmer, Claes Gustafsson, Matthew Tobin, Stephen del Cardayre, Phillip A. Patten, Jeremy Minshull, Lorraine J. Giver
-
Patent number: 7054756Abstract: In a bacteriological examination system, an expected range of drug sensitivity is calculated from the results of statistics of data acquired at past drug sensitivity tests. Testing panels accommodating drugs of different densities (ex. increasing by increments) covers the calculated expected range are selected for testing. An average-per-sample value of drug sensitivities of bacteria that reside in a hospital and an average-per-sample value of drug sensitivities of bacteria that reside in a limited region are preserved separately in a results-of-test database. A difference between statistical values of drug sensitivities of one bacterial species in a bacterial classification group residing in a hospital to an object drug and statistical values of drug sensitivities of the bacterial species residing in a limited region is calculated. The difference then is divided by the average-per-same value in the limited region.Type: GrantFiled: December 13, 2001Date of Patent: May 30, 2006Assignee: Hitachi, Ltd.Inventors: Kazuyuki Shimada, Hitoshi Matsuo, Satoshi Mitsuyama, Hitoshi Otake
-
Patent number: 7053205Abstract: The invention relates to compositions useful for the production of transgenic plants. In particular, the invention relates to Cassava vein mosaic virus (CsVMV) promoter sequences and expression cassettes containing CsVMV promoter sequences. The invention describes nucleic acid molecules, vectors and transgenic plants containing promoters derived from CsVMV promoter that are operatively linked to heterologous DNA sequences, and methods for producing transgenic plants containing these promoters.Type: GrantFiled: June 20, 1997Date of Patent: May 30, 2006Assignee: The Scripps Research InstituteInventors: Bertrand Verdaguer, Alexandre de Kochko, Roger N. Beachy, Claude Fauguet
-
Patent number: 7048931Abstract: Compositions and methods for the therapy and diagnosis of cancer, such as prostate cancer, are disclosed. Compositions may comprise one or more prostate-specific proteins, immunogenic portions thereof, or polynucleotides that encode such portions. Alternatively, a therapeutic composition may comprise an antigen presenting cell that expresses a prostate-specific protein, or a T cell that is specific for cells expressing such a protein. Such compositions may be used, for example, for the prevention and treatment of diseases such as prostate cancer. Diagnostic methods based on detecting a prostate-specific protein, or mRNA encoding such a protein, in a sample are also provided.Type: GrantFiled: November 9, 2000Date of Patent: May 23, 2006Assignee: Corixa CorporationInventors: Jiangchun Xu, Davin C. Dillon, Jennifer L. Mitcham, Susan L. Harlocker, Yuqiu Jiang, Steven G. Reed, Michael D. Kalos, Marc W. Retter, John A. Stolk, Craig H. Day, Yasir A. W. Skeiky, Aijun Wang
-
Patent number: 7033827Abstract: Compositions and methods for the therapy and diagnosis of cancer, particularly prostate cancer, are disclosed. Illustrative compositions comprise one or more prostate-specific polypeptides, immunogenic portions thereof, polynucleotides that encode such polypeptides, antigen presenting cell that expresses such polypeptides, and T cells that are specific for cells expressing such polypeptides. The disclosed compositions are useful, for example, in the diagnosis, prevention and/or treatment of diseases, particularly prostate cancer.Type: GrantFiled: May 9, 2002Date of Patent: April 25, 2006Assignee: Corixa CorporationInventors: Jiangchun Xu, Davin C. Dillon, Jennifer L. Mitcham, Susan L. Harlocker, Yuqiu Jiang, Robert A. Henderson, Michael D. Kalos, Gary R. Fanger, Marc W. Retter, John A. Stolk, Craig H. Day, Thomas S. Vedvick, Darrick Carter, Samuel X. Li, Aijun Wang, Yasir A. W. Skeiky, William T. Hepler, John Hural, Patricia D. McNeill, Raymond L. Houghton, Carlota Vinals y de Bassols, Teresa M. Foy, Yoshihiro Watanabe, Madeleine Joy Meagher, Ta Deng
-
Patent number: 7035740Abstract: Described herein are systems and methods for normalizing data without the use of external controls. Also described herein are systems and methods for analyzing cluster data, such as genotyping data, using an artificial neural network.Type: GrantFiled: March 24, 2004Date of Patent: April 25, 2006Assignee: Illumina, Inc.Inventor: Bahram Ghaffarzadeh Kermani
-
Patent number: 7031843Abstract: The invention described herein relates to computer and display methods and systems for acquiring, storing, manipulating, analyzing, linking, retrieving and displaying the data. The methods and systems are illustrated with reference to data on constituents of biological systems, particularly data on gene expression. In this regard, the invention especially relates to interactive systems for displaying gene expression-related data in three-dimensional molecular topographies. Expressed genes and their activity are represented as peaks in the topographies. Additionally, the invention relates to methods and systems for generating and displaying delta plots, which show differences in gene expression, and to methods and systems for generating molecular movies that show changes in gene expression. While illustrated by reference to gene expression, the methods and systems can be used to generate and manipulate displays of data on other complex populations.Type: GrantFiled: September 23, 1998Date of Patent: April 18, 2006Assignee: Gene Logic Inc.Inventors: Brian R. Bullard, Sean Mullins